The important proapoptotic activity of (-)-lentiginosine, the enantiomer of a natural glycosidase inhibitor, associated with its low cytotoxicity, suggests the study of the unknown receptor responsible for the triggering of the proapoptotic cascade. To this purpose derivatives of (-)-lentiginosine 7 and 8, which contain the biotin moiety as an affinity label and fluorescein as fluorophore, have been synthesized. Significantly, the compounds maintain a good activity as the hydroxylentiginosine precursor.
Introduction
Iminosugars have attracted a great deal of interest for their numerous potential applications as pharmacological tools in diseases involving the activity of glycosidases, glycosyltransferases and glycoprotein, in general. Among the different iminosugars (+)-lentiginosine (1) (Figure 1 ), a natural alkaloid, 6 has attracted our interest for the simplified structure, with respect to other iminosugars, compared to the important glycosidase inhibitory activity, 7, 8 and the more recently discovered activity as a good inhibitor of Hsp90 (Heat Shock Protein 90). 9 This interest was reinforced by the discovery that the non-natural enantiomer (-)-lentiginosine (2, Figure 1 ) is a potent proapoptotic agent against tumor cells with low toxicity towards normal cells. 10 This activity is also shared by the corresponding synthetic 7S-OH derivative 3 ( Figure 1 ). 11 Apoptosis, a form of programmed cell death that proceeds by a highly regulated mechanism, plays an important role in numerous diseases including cancer. Accordingly, the development of new pro-apoptotic molecules and the knowledge of their mechanism of action are major challenges in organic chemistry and biomedical sciences. Initial studies have disclosed that the activity of 2 is caspase dependent and involves activation of the intrinsic pathway of apoptosis, 12 but still many aspects of the mechanism of action of 2 need to be investigated. In particular, the specific receptor of the molecule that is able to start the cascade of events leading to apoptosis has yet to be identified.
Modification with molecular probes such as biotin and fluorophores provides a useful technique to investigate permeability through cell membranes, intracellular distribution, and cellular targets of biologically active compounds.
synthesis and biological evaluation of the model 1,2-dihydroxy-3-[(octylcarbamoyl)oxy]-indolizidine 5 ( Figure 2 ) revealed that an alkyl carbamate could be a suitable spacer between the indolizidine ring system and the chosen tags. Accordingly, a flexible C-10 carbon chain ,-functionalized with an isocyanate and an amino group was chosen as linker.
Herein, we report on the synthesis of the common intermediate 6 and its coupling with biotin and fluorescein. The proapoptotic activity of deprotected indolizidines 7 and 8 was also evaluated.
Results and Discussion
1,2-Diprotected 7-hydroxylentiginosine 9 was employed in this study as the key intermediate to produce lentiginosine conjugates. Enantiopure indolizidine 9 was synthesized starting from Dtartaric acid following recently published procedures (Scheme 1).
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Scheme 1. Synthetic approach to 7-hydroxylentiginosine 9.
The introduction of a carbamate group in the 7-position was performed by nucleophilic addition of the free hydroxy group of 9 to a suitable isocyanate. Intermediate 9b was reacted with the commercially available octyl isocyanate in the presence of TEA in anhydrous dichloromethane for 7 hours at room temperature. Simple removal of the solvent and treatment with the strongly basic resin Ambersep 900-OH in methanol to hydrolyze the benzoyl ester groups gave the deprotected carbamate 5 in 64% yield over two steps (Scheme 2).
Having established the possibility of the reaction of 9 with a long chain isocyanate, and encouraged by the conservation of the biological activity in the model compound 5 (see below), the next step was to prepare a long chain carbon isocyanate with a terminal amino group to link the molecular probe on lentiginosine. To this end, the inexpensive 11-aminoundecanoic acid (12) was protected with the Cbz group, 19 and then the free carboxylic group was converted into isocyanate through Curtius rearrangement of the corresponding acyl azide.
Following analogous approaches reported in the literature, [20] [21] [22] the formation of a carbamate in a one-pot reaction was attempted. Heating a solution of 9a and 13 in the presence of diphenylphosphoryl azide (DPPA) and a base afforded only traces of the desired product along with 7-(diphenoxyphosphoryloxy)-lentiginosine. No improvement was observed by adding alcohol 9a after acyl azido or isocyanate formation. [23] [24] [25] Fortunately, the stepwise approach was successful. Activation of 13 with ethyl chloroformate followed by treatment with sodium azide gave acyl azide 14 in good yield (Scheme 3). The reaction of amine 6 with fluorescein 5-isothiocyanate (FITC) occurred at room temperature in DMF/ Et 3 N to give the addition product that could not be purified and was in sequence treated with TFA to remove tert-butoxy protection quantitatively (Scheme 4). This product, that was submitted to tests as such, gave a correct ESI-MS (see Experimental Section), but an unresolved NMR spectrum, because of the broadening caused by the acid form. Removal of acid by basic treatment gave the free indolizidine base with correct NMR data.
The reaction of amine 6 with biotin under standard coupling reaction conditions afforded amide 16 in 79% yield (Scheme 4). Deprotection of biotinylated compound 16 by TFA, followed by basic treatment, gave the deprotected labelled (-)-lentiginosine 8, which was submitted as such for biological tests. 
Biological testing
Selected data on the effects of 4, 5, and 8 on both cell viability and apoptosis of MOLT-3 tumor cells are reported in Table 1 (for dose-effect data see Supporting Information). The three lentiginosine derivatives 4, 5, and 8 were not cytotoxic toward MOLT-3, exhibiting CC 50 (cytotoxic inhibitory concentration 50%) values >1000 μM. Conversely, the well-known cytotoxic chemotherapeutic agent 7-ethyl-10-hydroxycamptothecin (SN38), used as a positive control, was highly toxic. Apoptosis was assayed by flow cytometric quantification of hypodiploid nuclei.
26
Derivative 4 was unable to induce apoptosis, whereas 5 and 8 induced, respectively, 23% and 71% hypodiploid nuclei at a concentration of 500 µM. The colored fluorescein derivative 7·TFA could be tested only at low concentration and different assays will be necessary to get accurate results, but preliminary tests indicated a good pro-apoptotic activity as well. 
Conclusions
Lentiginosine derivative 6 decorated with a C-10 chain functionalized at the terminal position with an amino group was synthesised in good yield from 7-hydroxylentiginosine 9a and the amino acid 12. Intermediate 6 was coupled with FITC and biotin to get labeled (-)-lentiginosines 7 and 8 that showed an adequate pro-apoptotic activity on MOLT-3 tumor cell to be used as fluorescent and affinity probes in the identification of the molecular target of (-)-lentiginosine. The present study also validated the applicability of the carbamate group as a suitable tether at C-7 of lentiginosine with preservation of the pro-apoptotic activity and low cytotoxicity.
Experimental Section
General. Benzyl (11-azido-11-oxoundecyl)carbamate (14) . Freshly distilled triethylamine (0.067 mL, 0.48 mmol) was added to a solution of acid 13 (100 mg, 0.298 mmol) in anhydrous acetone (2.7 mL) cooled at -5 °C. Ethyl chloroformate (0.046 mL, 0.477 mmol) was added dropwise to the cold solution, then the reaction mixture was stirred for 30 min at 0 °C. A solution of sodium azide (39 mg, 0.596 mmol) in water (0.175 mL) was slowly added and the mixture was stirred for 1 h at 0 °C. The mixture was treated with ice and water (5 mL), then extracted with diethyl ether (5 mL × 3). The combined organic layers were sequentially washed with water (5 mL), saturated sodium bicarbonate (5 mL), and water (5 mL), dried with Na 2 SO 4 , filtered and concentrated under reduced pressure to afford 14 (96 mg, 89%) as a white solid, which was used in the next step without further purification. 1 
Benzyl
(1R,2R,7S,8aR)-1,2-di-tert-butoxyoctahydroindolizin-7-yl decane-1,10-diylbiscarbamate (15) . A solution of acyl azide 14 (59 mg, 0.16 mmol) in anhydrous toluene (6.8 mL) was heated at reflux for 30 min. A solution of 9a (42 mg, 0.15 mmol) in toluene (1.3 mL) was added, and the resulting reaction mixture heated at reflux for 5 h, then allowed to cool to rt. The solvent was evaporated under reduced pressure and the dry residue was purified by flash chromatography on silica gel (eluent: petroleum ether/AcOEt from 2:1 to 1:1) to obtain 15 (87 mg, 95%) as a white solid. R f 0.31 (petroleum ether/AcOEt 3:2 (3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'- 
(1R,2R,7S,8aR)-1,2-Di-tert-butoxyoctahydroindolizin-7-yl [10-[[5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]amino]decyl]carbamate (16).
To a solution of amine 6 (32 mg, 0.07 mmol) in CH 2 Cl 2 (0.50 mL), THF (1 mL) and water (1 mL), biotin (17.7 mg, 0.07 mmol) was added, the solution was cooled at 0 °C, then HOBt (13.4 mg, 0.10 mmol) and EDCI HCl (19 mg, 0.10 mmol) were added. The reaction mixture was stirred at rt for 12 h. Biological assays Cell culture. The human acute lymphoblastic T cell line MOLT-3 (Zooprofilactic Institute, Brescia, Italy) was cultured in Roswell Park Memorial Institute (RPMI) 1640 (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, Invitrogen), 2 mM glutamine (Hyclone, Cramlington, England, UK), 50 U/mL penicillin and 50 U/mL streptomycin (Hyclone). MOLT-3 was cultured at 37 °C under humidified 5% CO 2 atmosphere, in the presence or absence of 4, 5, and 8 at the concentrations of 10, 100, 250, 500 μM. The SN38 (a metabolite of irinotecan, a topoisomerase I inhibitor) at the concentration of 10 μM was used as positive control in MTS and apoptosis assays.
Evaluation of apoptosis. Apoptosis was evaluated, after 18 h of incubation, by flow cytometry analysis of hypodiploid events following treatment of the cells with detergent and PI staining, using a method that distinguishes nuclei from apoptotic, necrotic or viable cells, as previously described. 26 Isolated nuclei were analyzed using a FACScan flow cytometry (BD Biosciences, San Josè, CA). Detectors and amplifier gains for forward and orthogonal scatter were adequately selected in order to simultaneously detect nuclei from viable, apoptotic and necrotic cells. Events were gated on forward versus orthogonal scatter in such a way that degraded DNA from cell debris or from doublets was excluded, and nuclei from viable, apoptotic and necrotic cells were assayed. Data acquisition and analysis were performed using CellQuestTM software on a minimum of 5000 events for each sample (BD Biosciences, San Josè, CA).
MTS assay. Cell metabolic activity, measured by reduction of MTS to formazan, was evaluated using a colorimetric commercial kit, MTS (Cell Titer 96 Aqueous One Solution, Promega). The assay was performed by seeding 1 × 10 4 MOLT-3, in 100 μL in the presence or absence of 4, 5, and 8 at seven different concentrations, from 1 to 1000 μM in complete medium RPMI supplemented with 5% FBS. After 24 hours, twenty microliters of "Cell Titer 96 Aqueous One Solution Reagent" was added directly to culture wells at the end of the culture, incubated for 1-4 h and then absorbance was read at 490 nm.
Calculation of inhibitory concentration.
Cumulative results from at least three different determinations were used to calculate the drug concentration required to inhibit mitochondrial enzyme activity by 50% (CC 50 ), as evaluated by MTS assay in all cell lines. The CC 50 were calculated according to the best-fit curve, y value versus log x, where y is the value of the examined function and x is the drug concentration.
